Clinical guidelines and definitions of autoinflammatory diseases: Contrasts and comparisons with autoimmunity- A comprehensive review

Clinical Reviews in Allergy and Immunology

Volumn 45, Issue 2, 2013, Pages 227-235

  Zen, M ^a   Gatto, M ^a   Domeneghetti, M ^a   Palma, L ^a   Borella, E ^a   Iaccarino, L ^a   Punzi, L ^a   Doria, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adaptive immunity; Autoimmune diseases; Autoinflammatory diseases; Inflammasome; Innate immunity

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHLOROQUINE; COLCHICINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CRYOPYRIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYTOKINE; FERRITIN; IMMUNOGLOBULIN D; IMMUNOSUPPRESSIVE AGENT; INFLAMMASOME; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; METHOTREXATE; MEVALONIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PATTERN RECOGNITION RECEPTOR; PHOSPHOLIPID ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG;

ACNE; ADAPTIVE IMMUNITY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BACTERIAL ARTHRITIS; BEHCET DISEASE; BLAU SYNDROME; BLOOD LEVEL; CHRONIC DISEASE; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; CLINICAL LABORATORY; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; CROHN DISEASE; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FOLLOW UP; GENE LOCUS; GENETIC PREDISPOSITION; GOUT; HOST PATHOGEN INTERACTION; HUMAN; HYPERIMMUNOGLOBULINEMIA; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOPROLIFERATIVE DISEASE; MIXED CONNECTIVE TISSUE DISEASE; MOLECULE; NONHUMAN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATHOGENESIS; PATIENT MONITORING; POLYENDOCRINOPATHY; POLYMYOSITIS; PRACTICE GUIDELINE; PROGNOSIS; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TREATMENT INDICATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URINE LEVEL;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL EVOLUTION; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; PLANTS; PRACTICE GUIDELINES AS TOPIC;

EID: 84884904175     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8355-1     Document Type: Review

References (69)

1. Sanabria N, Goring D, Nürnberger T, Dubery I (2008) Self/nonself perception and recognition mechanisms in plants: a comparison of self-incompatibility and innate immunity. New Phytol 178:503-514
2. Ohta Y, Okamura K, McKinney C, Bartl S, Hashimoto K, Flajnik MF (2000) Primitive synteny of vertebrate HC class I and class II genes. Proc Natl Acad Sci USA 97:4712-4717
3. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX (2007) Adaptive immune cells temper initial innate responses. Nat Med 10:1248-1252
4. Toitou I (2012) New genetic interpretation of old diseases. Autoimmun Rev 12(1):5-9
5. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L et al (2012) Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12(1):22-30
6. Masters SL, Somin A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory diseases. Annu Rev Immunol 27:621-668
7. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I et al (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71(10):1599-605
8. Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365:1612-1623
9. Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S et al (2012) Polymorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45:271-278
10. Punzi L, Scanu A, Ramonda R, Oliviero F (2012) Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev 12(1):66-71
11. Torgerson TR, Ochs HD (2007) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 120:744-750
12. Worth A, Thrasher AJ, Gaspar HB (2006) Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 133:124-140
13. Pétrilli V, Dostert C, Muruve DA, Tschopp J (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19:615-622
14. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N et al (2010) Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 87:385-395
15. Doria A, Zampieri S, Sarzi-Puttini P (2008) Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 8:89-91
16. Shoenfeld Y, Agmon-Levin N (2011) 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4-8
17. Bassi N, Luisetto R, Del Prete D, Ghirardello A, Ceol M, Rizzo S et al (2012) Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Lupus 21:203-209
18. Kastner DL, Aksentijevich KI, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784-790
19. Aringer M, Smolen JS (2012) Therapeutic blockade of TNF in patients with SLE-promising or crazy? Autoimmun Rev 11(5):321-325
20. Doria A, Sherer Y, Meroni PL, Shoenfeld Y (2005) Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am 31:355-362
21. Stojanovich L (2010) Stress and autoimmunity. Autoimmun Rev 9:271-276
22. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229-265
23. Konè-Paut I, Piram M (2012) Targeting interleukin-1β in CAPS [cryopyrin-associated periodic] syndromes: what did we learn? Autoimmun Rev 12(1):77-80
24. Lamkanfi M, Walle LV, Kanneganti TD (2011) Deregulated inflammasome signaling in disease. Immunol Rev 243:163-173
25. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES et al (2012) Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 11:596-603
26. Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A et al (2010) IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 69:1704-1710
27. Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L (2012) Blau syndrome, clinical and genetic aspects. Autoimmun Rev 12(1):44-51
28. Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG et al (2012) The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev 12(1):10-13
29. Soriano A, Manna R (2012) Familial Mediterranean fever: new phenotypes. Autoimmun Rev 12(1):31-37
30. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M (2006) Lupus erythematosus and the skin. Clin Exp Rheumatol 24:S26-S35
31. Drenth JP, Boom BW, Toonstra J, Van der Meer JW (1994) Cutaneous manifestations and histologic findings in hyperimmunoglobulin D syndrome. International Hyper IgD Study Group. Arch Dermatol 130:59-65
32. Lamprecht P, Moosig F, Adam-Klages S, Mrowietz U, Csernok E, Kirrstetter M et al (2004) Small vessel vasculitis and relapsing panniculitis in tumor necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 63:1518-1520
33. Riera E, Olivé A, Narváez J, Holgado S, Santo P, Mateo L et al (2011) Adult onset Still's disease: review of 41 cases. Clin Exp Rheumatol 29:331-336
34. Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG et al (2012) Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev 12(1):38-43
35. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC (2006) Update on idiopathic inflammatory myopathies. Autoimmunity 39:161-170
36. Di Pietra L, Gardiman M, Terranova C (2012) Postpartum maternal death associated with undiagnosed Hodgkin's lymphoma. Med Sci Law 52:174-177
37. Uttenthal BJ, Layton DM, Vyse TJ, Schreiber BE (2012) Clinical problem-solving. The wolf at the door. N Engl J Med 366:2216-2221
38. Ebert EC, Hagspiel KD (2011) Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol 45:436-441
39. Maestroni S, Di Corato PR, Cumetti D, Salvatore S, Ghidoni S, Prisacaru L et al (2012) Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 12(1):60-65
40. Merlini G, Obici L (2012) Amyloidosis in autoinflammatory syndromes. Autoimmun Rev 12(1):14-17
41. Nakamura T (2011) Amyloid A, amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol 29:850-857
42. Doria A, Cutolo M, Ghirardello A, Zen M, Villalta D, Tincani A et al (2012) Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther 14:R66
43. Higgs BW, Zhu W, Richman L, Fiorentino DF, Greenberg SA, Jallal B et al (2012) Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Int J Rheum Dis 15:25-35
44. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A et al (2007) Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 1108:227-239
45. Martini A (2012) Systemic juvenile idiopathic arthritis. Autoimmun Rev 12(1):56-59
46. Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol 2011; doi: 10.1007/s12016-011-8264-0
47. Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M et al (2012) Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol 30(6):856-863
48. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G et al (2012) Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and antiviral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 11(11):815-820
49. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L et al (2011) Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev 10:553-558
50. Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R et al (2011) Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 29:50-56
51. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D et al (2004) Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmunity 22:235-240
52. Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A (2009) Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 8:645-649
53. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S et al (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32:79-84
54. Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A et al (2003) Recombinant anti-P proteins autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 60:588-598
55. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F et al (2012) Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology 51:157-168
56. Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Catani C et al (1996) Blotting pattern of IgG Anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 16:145-150
57. Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370-2374
58. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A (2011) Cutting edge issues in polymyositis. Clin Rev Allergy Immunol 41:179-189
59. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M et al (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305-310
60. Vigo G, Zulian F (2012) Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev 12(1):52-55
61. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10:55-60
62. Gattorno M, Federici S, Pelagatti MA, Caorsi R, Brisca G, Malattia C et al (2008) Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 28:S73-S83
63. Bhat A, Naguwa SM, Cheema GS, Gershwin ME (2009) Colchicine revisited. Ann N Y Acad Sci 1173:766-773
64. Shugaiv E, Tüzün E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G (2011) Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol 29:S64-S67
65. Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A (2007) Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6:190-195
66. Rosenblum H, Amital H (2011) Anti-TNF therapy: safety aspects of taking the risk. Autoimmun Rev 10:563-568
67. Buch MH, Rubbert-Roth A, Ferraccioli G (2012) To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50. Autoimmun Rev 11:558-562
68. Caorsi R, Federici S, Gattorno M (2012) Biologic drugs in inflammatory syndromes. Autoimmun Rev 12(1):81-86
69. Atzeni F, Sarzi-Puttini P, Gorla R, Marchesoni A, Caporali R (2011) Switching rheumatoid arthritis treatments: an update. Autoimmun Rev 10:397-403